Der Goldene Schlüssel der ADHS Medikation

About this video

• Video Title: Der Goldene Schlüssel der ADHS Medikation
• Channel: ADHS verstehen mit Mark
• Speakers: Mark (inferred from channel name and narration)
• Duration: 00:07:53

Overview

This video explains how to find the optimal ADHD medication by understanding the molecular basis of ADHD symptoms. The speaker, Mark, shares his extensive research into psychiatric and pharmacological literature, identifying a pattern to simplify medication adjustment. He discusses the role of dopamine and norepinephrine in ADHD symptoms and suggests different medication strategies, including monotherapy with stimulants and combination therapies, based on symptom presentation and neurochemical imbalances.

Key takeaways

• Stimulant Monotherapy as a Starting Point: For many, starting with a stimulant medication is recommended. The dosage should be gradually increased until symptoms improve or worsen, indicating the optimal dose is the one before the worsening.
• Understanding Symptom Origins: ADHD symptoms can stem from different neurochemical imbalances (e.g., too little or too much dopamine, too little or too much norepinephrine), necessitating individualized treatment.
• Identifying Medication Needs:
  • If stimulants lead to concentration and reduced impulsivity/hyperactivity, it suggests a need for increased dopamine and norepinephrine.
  • If stimulants improve concentration but internal tension remains, it indicates low dopamine and high norepinephrine, potentially requiring a combination of stimulants and Guanfacine.
  • If stimulants reduce impulsivity/hyperactivity but worsen concentration, it suggests high dopamine and low norepinephrine, possibly requiring atypical antipsychotics like Aripiprazole and Atomoxetine.
  • If stimulants worsen both concentration and impulsivity/hyperactivity, it suggests high dopamine and high norepinephrine, potentially requiring Aripiprazole and Guanfacine.
• Beyond Stimulants: For cases where stimulant monotherapy is insufficient, combination treatments are discussed, involving medications like Guanfacine, Aripiprazole, and Atomoxetine, which target specific neurotransmitter imbalances.